• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300158.SZ
Share

Shanxi Zhendong Pharmaceutical Co.,Ltd Stocks

CN¥ 5.12Last Updated 26.05.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

CN¥ 770.87M

CN¥ 5.12
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers cancer drugs, cardiovascular drugs, infectious disease drugs, and respiratory drugs; antibiotics, antitumor drugs, vitamins, etc.; Chinese medicines; calcium preparations; and active pharmaceutical ingredients, as well as sells gastrointestinal drugs. The company offers its products in various dosage forms, such as large volume injections, small volume injections, powder injections, lyophilized powders, tablets, hard capsules, granules, dry suspensions, ointments, psychotropic substances, and other formulations Shanxi Zhendong Pharmaceutical Co.,Ltd is based in Changzhi, China.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 07:00

The founder of Yardeni is not expecting a market bubble. He named the main driver of the year

28.05.2026 03:46

Boeing has been authorized to increase production of the 737 Max. It is its best-selling airliner

28.05.2026 01:26

All three major U.S. indexes hit records - the first time that has happened this year

27.05.2026 23:51

JPMorgan in search of a big deal: Dimon admits to a takeover worth up to $20 billion

27.05.2026 23:18

Has the energy shock reached Europe? Britons' energy costs set to soar to a two-year peak

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026